Wednesday, May 2, 2012

India's First Grant of Compulsory Licence

By - GIIP: A pioneer Institute in IP Training | IP Courses | IP Education | IP Program

India’s first compulsory licence has been granted by the Indian Patent Office to Hyderabad-based drug-maker, Natco. The compulsory licence allows Natco to manufacture the active ingredient as protected by Bayer’s patent on Sorafenib Tosylate, IN 215758 (granted in 2008).

Bayer’s drug Nexavar, containing active ingredient, Sorafenib Tosylate, was first launched in 2005 for the treatment of Kidney Cancer which, later, in 2007, also received approval for the treatment of Liver cancer. Nexavar, although is not a life saving drug, has shown to extend life of a patient for around 4-5 years in kidney cancer and around 6-8 months in liver cancer.

Bayer had received the approval for importing and marketing the drug in India in 2008 and had always been marketing the drug in India by importing the drug. Natco received DCGI licence to market the drug in India, in April 2011. Subsequent to Natco receiving DCGI licence, Natco had approached Bayer to seek a voluntary licence for manufacturing and marketing the drug in India. Natco’s request for voluntary licence never materialized, following which Natco filed for a compulsory licence in July 2011.

LANDMARK JUDGMENT
The 62-page judgment by the Controller of Patents (Mr. P.H. Kurian), under the amended Indian Patents Act (2005), allows Natco to make and sell a similar version of Bayer's Nexavar in India. The judgment reasoned that the patent-holder, Bayer, had not met the reasonable requirement of the public. It had not “worked the patent” or manufactured it to a reasonable extent in India. Also, the drug was not available at an affordable price. With the compulsory licence granted, Natco will have to pay Bayer a royalty fixed at six per cent of net sales, every quarter.  The order also makes it obligatory for Natco to supply the drug free of cost to at least 600 needy patients per year.

COMPULSORY LICENCE
A compulsory licence is an authorization granted by the government in accordance with the grounds described under section 84 of the Indian Patent Act, 1970.

Section 84(1) of the Indian Patent’s Act allows any interested person to make an application to the Controller for grant of compulsory licence on a patent after the termination of three years from the date of grant of the patent on any of the following grounds:
(a) that the reasonable requirements of public with respect to the patented invention have not been
satisfied, or
(b) that the patented invention is not available to the public at a reasonably affordable price, or
(c) that the patented invention is not worked in the territory of India.


REASONING BY THE CONTROLLER
The Controller gave his reasoning separately on each of the above grounds and concluded that all the grounds are satisfied in granting a compulsory Licence against Bayer. Following are the reasoning cited by the controller:


84 (1) (a): Reasonable requirements of public are not satisfied
Controller noted that the drug is available to little above 2% of the eligible patients in India and thus reasonable requirements of the public are not satisfied. One of the reasons given by Bayer for lesser sales of the patented drug by Bayer in India was that Cipla makes a similar infringing drug for Indian market at a lesser price. However, The Controller did not take this into consideration saying that the demand in the market for the patented drug has to be fulfilled by the patentee and not a third party. The Controller stressed on the fact that Form 27 (Working of invention statement) filed by Bayer in 2009 and 2010, show only an insignificant quantum (only Rs. 2 Crore for 2009) of possible sales for the eligible patients.


84 (1) (b): Non-availability at reasonably affordable price

The drug by Bayer has to be taken by the patient throughout his lifetime and the cost of therapy is Rs. 2,80,428/- per month and Rs. 33,65,136/- per year. The applicant submitted that the price of the patented product is too high and simply not affordable by common man making the product inaccessible and out of reach. The applicant further said that it is an abuse of monopolistic rights and such a practice is unfair and anti-competitive.  The patentee argued that the price includes the R&D costs as well as it pays for the pipeline (for future innovation). Also, “reasonableness” is a relative term which needs to be interpreted as per circumstances. “Reasonably” should mean reasonable to the ‘patients’ and ‘patentee’ as well. The Controller after going through all evidences said, “I am of the view that reasonably affordable price has to be construed predominantly with reference to the public… I conclude beyond doubt that the patented invention was not available to public at a reasonably affordable price and that Section 84(1)(b) of The Patent Act, 1970 is invoked in this case”


84 (1) (c): Non-working in the territory of India
The Controller after consulting the international agreements on intellectual property including TRIPS,
Paris convention and the Indian Patent Act, concluded that Bayer failed to work on the patent in the territory of India. He further said, “In the instant case, the Patent was granted in the year 2008. It is an admitted fact that the Patentee does have manufacturing facilities for manufacturing drugs in India, including oncology drugs. However even after the lapse of four years from the date of grant of patent, the Patentee failed to do so. The Patentee has also failed to grant a voluntary licence on reasonable terms to anyone including the Applicant herein to work the invention within the territory of India. Accordingly, I hold that Section 84(1)(c) is attracted in this case..”


ORDER
The Controller granted a compulsory licence under Section 84 of Indian Patent Act, 1970 to M/s Natco Pharma Ltd., Hyderabad for Bayer’s Patent IN215758 on 9th of March 2012. Natco’s compulsory licence would make the drug available to public at a much reduced price. The drug which costs patients around Rs. 2.8 Lakhs/ month through Bayer, would now be available to public at just around Rs. 8800/month.


IMPACT
This grant of compulsory licence will trigger other companies to file their applications against patented products of MNCs in same lines. Also, this decision may make the MNCs to consider the differential pricing structure for selling drugs for different (rich/intermediate/poor) segments of people in India. This decision will definitely have positive impacts on the patients suffering from kidney and liver cancers in India, who were not able to afford high treatment cost previously.

Incidentally, this was Mr. Kurian’s last assignment. He has now handed over the charge of The Controller at Patent Office to Mr. Chaitanya Prasad.

The Gamut of Intellectual Property in the Software Industry


By - GIIP: A pioneer Institute in IP Training | IP Courses | IP Education | IP Program
-Prologue-
Amongst the challenges that are prevalent in the software industry, one of the most contentious ones are the issues related to intellectual property. The controversies have brought the Knights face to face. On one hand there is an increasing need of protecting the blooming software industry and on the other, even a bigger challenge to avoid from ending up  sharing the umbrella of protection   with what has been defined as ‘The non-patentable’. With the increasing   conflicts in the global intellectual property practices in the case of software, there has emerged multiple schools of thought, each providing their own way of how it must be managed.  This paper aims at throwing light on the whole gamut of Intellectual Property practices prevalent in the current software Industry described through various schools of thought. By virtue of this paper, the author intends to share a note of concern amongst those who have a diminished focus on intellectual property, in the Indian software sector.
While most of the firms and Organizations are reluctant to take the slightest of risk in producing their goods, most are less diligent when it comes to intellectual property. As a result the competitors are taking the software developers for a ride. Intellectual Property needs to be addressed not only at the management level, however at all the levels in the hierarchy of an Organization, and across the software Industry.
While the Indian corporate software industry is picking up flame, the issues of Intellectual property on the other hand seem to have been put to a back burner. With the software Industry as a prominent player, in terms of economic growth, time has now come for countries like India to peal and look deeper and address to the issues associated with this sector.

IP - ‘ A kaleidoscope’
In order to see the wide spectrum of Intellectual property protection, it is important to see it from the  different windows of the various schools of thought. One, in the background of technology, the other from a legal prospective and the last (but not the least), from a business prospective.
From a Technological Point of View- It refers to the kind , nature and type of a software(s) prevalent during, or over a period of time with respect to changing trends in technology and the difficulty in defining and setting up appropriate Intellectual Property protection it its context.
From a Legal prospective- It refer to the domestic and global laws defining legal boundaries to technological innovations.
From a Business prospective- It refers to the way the software business in India is conducted and its repercussions on software and intellectual property management.

Software Patenting – ‘A hurdle Race’
Getting a software patented at the Patent Office is no less than a hurdle race for the emerging software developers. Controversies arise over proof of novelty and questions of non-obviousness, leaving behind the software developers reluctant and confused about choosing the right path to take to protect their creativity.  This is more a problem of the patent office than that of the developer. The central test for patentability is inventiveness and much greater  emphasis should be laid on this aspect of the examination process. Patent office examiners should be firm and less inclined to give the benefit of doubt. It is beyond any doubt that there is a tough fight out there for the software developers to get a patent on their software at the patent office, however never the less , the software developers are drifting their way to an easy escape by consistently trying to define their creativity in the ambit of the definition of ‘patentable inventions’.
Typically, Intellectual property right, is the ‘right of the one who invents’. An Intellectual Property protection topology that best fits ‘software’ has had no consensus for over  a decade in India. The degree to which an inventor and an invention can be proved in software will determine the type of protection that will be used by the software developers over the period of time.

Conclusion
As per the present Patent regime, the TRIPS Agreement is not likely to come out with a different perspective on software in the near future. This leaves the software developers with an open battle field to be conquered. Amongst the possible routes like patents,, copyrights, licensing , it is the decision of the software developers to be seen that shall decide the fate of this industry in context of Intellectual Property Protection, over the coming years.
Indian patent examiners have to be in a position to award software patents to a computer program that is not ’a computer program per se’. The tendency for India to keep its intellectual property, whether in the form of copyright, patent or trade secret, will be largely determined by its actual role in the early phases of software development.

Author - Anant Jain (IP ASSOCIATE)
Global Institute of Intellectual Property 

Monday, April 9, 2012

Post Graduate Diploma (PGD) in Intellectual Property Rights and Patent Management 2012

Post Graduate Diploma in Intellectual Property Rights and Patent Management program starting from 2nd July 2012 is designed for participants with BE, BTech, B.Pharm, MS, MTech, M.Pharm, PhD. The curriculum has been designed and developed, keeping the industry requirements at core, by IP Practitioners, Attorneys and Patent Examiners & Agents

The program curriculum is tailored to meet industry requirements as well as the needs of aspiring professionals. It includes up-to-date education in US, European and Indian Patent and IP laws and procedures and is designed and delivered by outstanding professionals with rich teaching, research, industry and consulting experience.

The PGD program is divided into three trimesters - the first two trimesters includes class room training followed by 3 months of paid internship. GIIP will arrange for Industry internship for all program participants.

On completion of the program, prticipants will be placed as a Patent Engineer / Analyst or Patent Associate with a leading Corporate, MNC, Law Firm or KPO.

About GIIP
Global Institute of Intellectual Property is a leading Intellectual Property (IP) training company, co-headquartered at New Delhi, India and San Jose, USA. The company has been set up by a team of successful entrepreneurs, IP attorneys, patent agents and practitioners. GIIP provides training services covering IP generation, protection, commercialization and management.

GIIP recognizes the growing demand of patent and related services globally and also the growing need for qualified & trained patent professionals, agents and IP litigation attorneys in India.

Sunday, November 13, 2011

Off Campus (IP) Learning Program has Advantage over Distance Learning Courses

OCL - http://ocl.giipinfo.com

GIIP Off-Campus IP Learning Program aims at making IP learning more easily available, cost-effective and convenient to a broader constituency of learners. The OCL programs have more Advantages than Distance Learning Courses. It’s flexible, user-defined delivery mode and is tailored to meet the needs of a wide category of users, ranging from scholars to researchers to technical professionals. The program allows for learning at any time, any place and GIIP’s online learning system facilitates constant interaction with the trainers and mentors. A user can undertake a complete capsule or individual modules to meet his/her specific needs.


The Off-Campus IP Learning program is an extension of GIIP’s existing instructor led training programs which is more comprehensive than distance learning courses. It will impart IP knowledge and skills to uses with technical, legal and management background. The Off-Campus IP Learning program provides comprehensive knowledge about different forms of Intellectual Property (IP), related protection systems & their significance, infringement issues and strategies for commercialization and management. The program curriculum covers state of the art education in IP laws of India, US and EP and provides practical insights supported by illustrations, case studies and exercises that simulate scenarios commonly faced by a mid size to large enterprises handling IP issues. The focus is on actual day-to-day intellectual property issues faced by a technology-based company.

The Off-Campus IP Learning suite of products are designed for different users – a) Students and Working Professionals, b) R&D professionals and Research Scientists /Associates and c) Corporate; and each product is further categorized as Basic, Advanced and Expert to suit the particular user needs or competency.

The Off-Campus IP Learning product for Students and Working Professionals, called the "IPNucleus”, is now available and offers the following capsules:

• IPNucleus Basic - includes course material (hard copy, online material or a combination of both) interaction with the trainer by email, phone or fax, assessment of each module upon completion and final examination and certification
• IPNucleus Advanced - includes features of the IPNucleus Basic capsule and three 2-day sessions (instructor led classes) at the beginning, middle and end of the capsule.
• IPNucleus Expert – includes features of the IPNucleus Advanced capsule followed by two months of internship at a leading Corporate, MNC, KPO or Law Firm

The OCL - IPNucleus program is designed for graduates, post-graduates, research associates and working professionals from the ICT, Automobile, Pharmaceutical, Biotechnology, Chemical, Heavy Engineering, Petrochemical and KPO & LPO industry. Some of the modules are also meant for professionals with legal (LLB, LLM) background.


Thursday, September 22, 2011

GIIP Online IP Learning Program

The objective of Online IP Learning Program IPNucleus is to make IP learning more easily available, cost-effective and convenient to a broader constituency of learners. The IPNucleus program is an extension of GIIP’s existing instructor led training programs and will impart IP knowledge and skills to uses with technical, legal and management background.

GIIP Online IP Learning Program IPNucleus allows for learning at any time, any place and GIIP’s online learning system facilitates constant interaction with the trainers and mentors. A user can undertake a complete capsule or individual modules to meet his/her specific needs. IPNucleus program provides comprehensive knowledge about different forms of Intellectual Property (IP), related protection systems & their significance, infringement issues and strategies for commercialization and management. GIIP Online IP Learning Program IPNucleus curriculum covers state of the art education in IP laws of India, US and EP and provides practical insights supported by illustrations, case studies and exercises that simulate scenarios commonly faced by a mid size to large enterprises handling IP issues.

The IPNucleus is available with following capsules:

  • IPNucleus Basic - includes course material (hard copy, online material or a combination of both) interaction with the trainer by email, phone or fax, assessment of each module upon completion and final examination and certification
  • IPNucleus Advanced - includes features of the IPNucleus Basic capsule and three 2-day sessions (instructor led classes) at the beginning, middle and end of the capsule.
  • IPNucleus Expert – includes features of the IPNucleus Advanced capsule followed by two months of internship

GIIP Online IP Learning Program IPNucleus is designed for graduates, post-graduates, research associates and working professionals from the ICT, Automobile, Pharmaceutical, Biotechnology, Chemical, Heavy Engineering, Petrochemical and KPO & LPO industry. Some of the modules are also meant for professionals with legal (LLB, LLM) background.

Monday, September 12, 2011

Distance Learning Programme – OCL (Off Campus IP Learning)

GIIP Distances Learning Programme - OCL starting from 25th August, 2011 aims at making IP learning more easily available, cost-effective and convenient to a broader constituency of learners. The OCL programme is an extension of GIIP’s existing instructor led training programs and will impart IP knowledge and skills to uses with technical, legal and management background.

The Distance Learning programme allows for learning at any time, any place and GIIP’s online learning system facilitates constant interaction with the trainers and mentors. A user can undertake a complete capsule or individual modules to meet his/her specific needs. The Distance Learning (OCL) programme provides comprehensive knowledge about different forms of Intellectual Property (IP), related protection systems & their significance, infringement issues and strategies for commercialization and management. The Distance Learning programme curriculum covers state of the art education in IP laws of India, US and EP and provides practical insights supported by illustrations, case studies and exercises that simulate scenarios commonly faced by a mid size to large enterprises handling IP issues.

The OCL product for Students and Working Professionals, called the "IPNucleus”, is now available and offers the following capsules:

IPNucleus Basic - includes course material (hard copy, online material or a combination of both) interaction with the trainer by email, phone or fax, assessment of each module upon completion and final examination and certification

IPNucleus Advanced - includes features of the IPNucleus Basic capsule and three 2-day sessions (instructor led classes) at the beginning, middle and end of the capsule.

IPNucleus Expert – includes features of the IPNucleus Advanced capsule followed by two months of internship

The Distance Learning programme OCL is designed for graduates, post-graduates, research associates and working professionals from the ICT, Automobile, Pharmaceutical, Biotechnology, Chemical, Heavy Engineering, Petrochemical and KPO & LPO industry. Some of the modules are also meant for professionals with legal (LLB, LLM) background.


ABOUT GIIP

GIIP provides Consulting, Technical and Training services covering Intellectual Property generation, protection, commercialization and management. GIIP has been involved in capacity building for IP & patent professionals for the past 4 years and has trained more than 150 professionals in the PG Diploma and Certificate courses and over 1000 corporate employees.

GIIP has IITD, National Law University Delhi, Ministry of MSME, CSIR, University of Washington, USA as training partners and has earned the reputation of a leader in the field of IP education & training. GIIP also has a very strong association with the Industry and has conducted corporate training for companies, such as, Siemens, Philips, Infosys, HCL, TVS Motors, Evalueserve, CSIR, CDAC, Alstom, RIL, EIL, Ranbaxy, Panacea Biotech, Sanofi Aventis, Dabur, K&S Partners, etc.


For further information call 011-30884000 Email: ocl@giipinfo.com




Tuesday, August 2, 2011

Global Institute of Intellectual Property (GIIP) Launches Off-Campus IP Learning

Global Institute of Intellectual Property, a leading Intellectual Property (IP) training company, is pleased to launch its Off-Campus IP Learning programme and is inviting applications for the same. The programme aims at making IP learning more easily available, cost-effective and convenient to a broader constituency of learners. The Off-Campus IP Learning programme is an extension of GIIP’s existing instructor led training programs and will impart IP knowledge and skills to uses with technical, legal and management background.

The Off-Campus IP Learning programme offers flexible, user-defined delivery mode and is tailored to meet the needs of a wide category of users, ranging from scholars to researchers to technical professionals. The programme allows for learning at any time, any place and GIIP’s online learning system facilitates constant interaction with the trainers and mentors. A user can undertake a complete capsule or individual modules to meet his/her specific needs. .

The Off-Campus IP Learning programme provides comprehensive knowledge about different forms of Intellectual Property (IP), related protection systems & their significance, infringement issues and strategies for commercialization and management. The programme curriculum covers state of the art education in IP laws of India, US and EP and provides practical insights supported by illustrations, case studies and exercises that simulate scenarios commonly faced by a mid size to large enterprises handling IP issues. The focus is on actual day-to-day intellectual property issues faced by a technology-based company.

The Off-Campus IP Learning suite of products are designed for different users – a) Students and Working Professionals, b) R&D professionals and Research Scientists /Associates and c) Corporate; and each product is further categorized as Basic, Advanced and Expert to suit the particular user needs or competency.

The Off-Campus IP Learning product for Students and Working Professionals, called the "IPNucleus”, is now available and offers the following capsules:
  • IPNucleus Basic - includes course material (hard copy, online material or a combination of both) interaction with the trainer by email, phone or fax, assessment of each module upon completion and final examination and certification
  • IPNucleus Advanced - includes features of the IPNucleus Basic capsule and three 2-day sessions (instructor led classes) at the beginning, middle and end of the capsule.
  • IPNucleus Expert – includes features of the IPNucleus Advanced capsule followed by two months of internship at a leading Corporate, MNC, KPO or Law Firm
While announcing the Off-Campus IP Learning, GIIP’s CEO Mr. Atulya Nath said, “We are glad to offer this programme as it is in accordance with our endeavor to reach out to the masses and make them IP savvy. The Off-Campus IP Learning is a mode of delivery which is predominantly delivered online via our learning management system or supported by supplementary material that is posted to the user - including print-based materials, online web access and CD ROMs. Users will need to have access to a computer with an Internet connection and a CD/DVD ROM drive, in order to study off-campus modules.”

The IPNucleus programme is designed for graduates, post-graduates, research associates and working professionals from the ICT, Automobile, Pharmaceutical, Biotechnology, Chemical, Heavy Engineering, Petrochemical and KPO & LPO industry. Some of the modules are also meant for professionals with legal (LLB, LLM) background.
The fee for the IPNucleus Basic capsule is Rs. 27500/-, for the IPNucleus Advanced capsule is Rs.45000/- and for the IPNucleus Expert capsule is Rs. 75000/-. The date of commencement of the IPNucleus programme is 25th August, 2011 and applications will be accepted throughout the year. To enroll, candidates must complete an application form which is available on GIIP’s website

About GIIP
Global Institute of Intellectual Property (GIIP), a training institute co-headquartered in New Delhi, India and San Jose, USA, has been set up by a team of successful entrepreneurs, IP Attorneys, patent agents and IP practitioners. GIIP offers diploma, executive and corporate programs to develop professional skills in the field of Intellectual Property services, particularly International Patents and Procedures and enable them to serve global customers.

GIIP has IITD, National Law University Delhi, Ministry of MSME, CSIR, University of Washington, USA as training partners and has earned the reputation of a leader in the field of IP education & training. GIIP also has a very strong association with the Industry and has conducted corporate training for companies, such as, Honeywell, Infosys, GE, Symantec, HCL, TCS, Siemens, Evalueserve, Altacit Global, Lexadigm, CPA Global, Ripple IP Services, Inventurus, Ius-Juris, IPpro Inc., Panacea Biotech, Sanofi Aventis, Biocon, Ranbaxy Laboratories, Dabur, Jubiliant, Amarchand & Mangaldas, Anand & Anand, K&S Partners, Remfry & Sagar, etc.